Safety and Efficacy of Caffeine-Augmented ECT in Elderly Depressives: A Retrospective Study

Abstract

Prior studies have shown that in younger depressives undergoing ECT whose seizure durations declined despite maximum settings on three different ECT devices, pretreatment with caffeine lengthened seizures and resulted in clinical improvement. Caffeine (half life, 140-270 minutes) was well tolerated even in patients with pre-existing cardiovascular disease. The purpose of this retrospective study was to determine the safety and efficacy of caffeine augmented ECT in elderly depressed patients. The charts of 14 elderly depressives (average age 75.6, range 59-83; 2 males, 12 females) who received caffeine-augmented ECT were reviewed. Patients pre- and post-ECT medications, blood pressure, pulse, and seizure times (cuff and EEG) for each ECT performed were noted. The following conclusions were drawn from our study: (1) Caffeine definitely increases the seizure length and was useful in our setting when the energy settings could not be increased anymore. (2) Caffeine augmentation inconsistently causes an increase in pulse rate, on average, in the elderly. (3) Caffeine inconsistently produces an increase in mean arterial pressure. (4) Caffeine did not consistently produce an increase in the maximum rate-pressure product. We conclude from this study that caffeine-augmented ECT is safe and effective in increasing seizure duration in the elderly. However, more research needs to be done to determine optimal dosing and tolerability.

Get full access to this article

View all access options for this article.

References

1. Fink M. Theories of convulsive therapy: a neuroendocrine hypothesis. In: Lerer B , Weiner RD , Belmaker RH , Eds. ECT: basic mechanisms. London: John Libbey, 1984: 115–123.

2. Fink M , Johnson L. Monitoring the duration of electroconvulsive therapy seizures: ‘cuff’ and EEG methods compared. Arch Gen Psychiatry 1982; 39:1,189–191.

3. Shapira B , Zohar J , Newman M , et al. Potentiation of seizure length and clinical response to electroconvulsive therapy by caffeine pretreatment: a case report. Convulsive Therapy 1985; 1:58–60.

4. Hinkle PE , Coffey EC , Weiner RD , et al. Use of caffeine to lengthen seizures in ECT. Am J Psychiatry 1987; 144: 1143–1148.

5. Ottosson J-O . Experimental studies on the mode of action of electroconvulsive therapy. Acta Psychiatr Neurol Scand (Suppl) 1960; 145:1–141.

6. Weiner RD . The psychiatric use of electrically induced seizures. Am J Psychiatry 1979; 136:1507–1517.

7. Fink M , Johnson L. Monitoring the duration of electroconvulsive therapy seizures. Arch Gen Psychiatry 1982; 39:1189–1191.

8. Fink M. Convulsive therapy: theory and practice. New York: Raven Press, 1979.

9. Coffey CE , Figiel GS , Weiner RD , Saunders WB . Caffeine augmentation of ECT. Am J Psychiatry 1990; 147:579–585.

10.

10. Coffey CE , Weiner RD , Hinkle PE , et al. Augmentation of ECT seizures with caffeine. Biol Psychiatry 1987; 22:637–649.

11.

11. Weiner RD . The psychiatric use of electrically induced seizures. Am J Psychiatry 1979; 136:1507–1517.

12.

12. Fink M , Johnson L. Monitoring the duration of electroconvulsive therapy seizures. Arch Gen Psychiatry 1982; 39: 1189–1191.

13.

13. Shapira B , Lerer B , Gilboa D , et al. Facilitation of ECT by caffeine pretreatment. Am J Psychiatry 1987; 144:1199–1202.

14.

14. Ancill RJ , Carlyle W. Oral caffeine augmentation of ECT. Am J Psychiatry 1992; 149: 137.

15.

15. Jones RM . Rate pressure product. Anesthesia 1980; 35: 1010–1011.